Distress and PTSD in Patients with Cancer: Cohort Study Case
| Autor: | Nurka Pranjić, Amila Bajraktarevic, Enisa Ramic |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Original Paper
medicine.medical_specialty business.industry distress Panic Cancer Disease medicine.disease Hospital Anxiety and Depression Scale Distress Internal medicine medicine post-traumatic stress disorder psycho-oncology Anxiety medicine.symptom cancer patients Psychiatry business Depression (differential diagnoses) Cohort study |
| Zdroj: | Materia Socio-Medica |
| ISSN: | 1512-7680 |
| DOI: | 10.5455/msm.2016.28.12-16 |
| Popis: | Introduction: embarrassed emotional experience may affect the ability to oncology patient effectively cope with cancer, symptoms and treatment. Distress extends a long period, from common, normal feelings of vulnerability, sadness and fears to problems of PTSD, depression, anxiety, panic, social isolation and the perception of spiritual crisis. The aim of the research is to determine the level of distress and PTSD in cancer patients. Patients and Methods: In a prospective, cohort study cases from 2011- 2014 were included patients with cancer who are treated under the supervision of his chosen family medicine doctor. Including a factor for the participation of patients in the study is that from the moment of diagnosis of malignant disease passed 14 days-6 months n=39 patients. To achieve the set goals of the research was used instruments of 3 questionnaires: Questionnaire on the clinical characteristics of patients with malignant disease, demographic and individual characteristics; questionnaire distress oncology patient–hospital scales of depression and anxiety, HADS scale (Hospital Anxiety and Depression Scale - HADS) and a rapid test for self-assessment of the symptoms of PTSD. Results: Age of patients was 54.63 ± 11:46 years, and the age of the respondents when they were diagnosed with cancer 54.34 ± 11.26 years. The prevalence of distress was a high 76% 82x higher than expected), and PTSD 55%. Predictors of burnout syndrome in cancer patients are all important determinants of malignant disease: the time elapsed since the diagnosis of the disease which determines the clinical status of malignant disease (β=0.280; P=0.001; 95% CI, 0742-2259), discovered metastases (β=0.304; P=0.001; 95% CI -2621 to 0978) and treatments (β=0.160; P=0.031, 95% CI 0050 to 1.060). Conclusion: The problem of distress in cancer patients is widespread and has a high prevalence of 76% in our environment, while still absent intervention and treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|